Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

DOI

10.1007/s00415-019-09288-y

Type

Journal article

Journal

J Neurol

Publication Date

06/2019

Volume

266

Pages

1539 - 1540

Keywords

APMPPE—acute posterior multifocal placoid pigment epitheliopathy, Alemtuzumab, Autoimmunity, Multiple sclerosis, Adult, Alemtuzumab, Antineoplastic Agents, Immunological, Eye, Female, Humans, Multiple Sclerosis, Relapsing-Remitting, Treatment Outcome, White Dot Syndromes